Literature DB >> 24055213

Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.

Audrey M Wall1, Alan E Corcoran1, Ken D O'Halloran2, John J O'Connor3.   

Abstract

Chronic intermittent hypoxia (CIH) is an underlying component of obstructive sleep apnoea and has been shown to have deleterious and damaging effects on central neurons and to impair synaptic plasticity in the CA1 region of the rat hippocampus. CIH has previously been shown to impair synaptic plasticity and working memory. CIH is a potent inducer of hypoxia inducible factor (HIF), a key regulator in a cell's adaptation to hypoxia that plays an important role in the fate of neurons during ischemia. Levels of HIF-1α are regulated by the activity of a group of enzymes called HIF-prolyl 4-hydroxylases (PHDs) and these have become potential pharmacological targets for preconditioning against ischemia. However little is known about the effects of prolyl hydroxylase inhibition and CIH on synaptic transmission and plasticity in sub-regions of the hippocampus. Male Wistar rats were treated for 7-days with either saline, CIH or PHD inhibition (dimethyloxaloylglycine, DMOG; 50mg/kg, i.p.). At the end of treatment all three groups showed no change in synaptic excitability using paired pulse paradigms. However long-term potentiation (LTP) was impaired in the CA1 region of the hippocampus in both CIH and DMOG treated animals. LTP induced in the dentate gyrus was not significantly affected by either CIH or DMOG treatment. We also investigated the effect of 7-day CIH and DMOG treatment on the recovery of synaptic transmission following an acute 30min hypoxic insult. CIH treated animals showed an improved rate of recovery of synaptic transmission following re-oxygenation in both the CA1 and the dentate gyrus. These results suggest that LTP induction in the CA1 region is more sensitive to both CIH and DMOG treatments than the dentate gyrus.
© 2013.

Entities:  

Keywords:  2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid; AMP-activated protein kinase; AMPA; AMPK; BDNF; CA1; CIH; CREB; Chronic intermittent hypoxia (CIH); Cornu ammons 1 (CA1); DMOG; DMSO; Dentate gyrus (dentate gyrus); Dimethyloxaloylglycine (DMOG); EPO; HFS; HIF; Hypoxia inducible factor 1 alpha; LTP; Long term potentiation (LTP); MCAO; OSA; PDE4D; PHD; Prolyl hydroxylase domain (PHD); ROS; aCSF; artificial cerebrospinal fluid; brain derived neurotrophic factor; cAMP; cAMP response element-binding protein; chronic intermittent hypoxia; cornu ammonis 1; cyclic adenosine monophosphate; dimethyl sulfoxide; dimethyloxaloylglycine; erythropoietin; fEPSP; field excitatory postsynaptic potential; high frequency stimulation; hypoxia inducible factor; long-term potentiation; middle cerebral artery occlusion; obstrutive sleep apnoea; phosphodiesterase 4D; prolyl hydroxylase domain; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 24055213     DOI: 10.1016/j.nbd.2013.08.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  15 in total

1.  Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia.

Authors:  Audrey M Wall; Gatambwa Mukandala; Nigel H Greig; John J O'Connor
Journal:  J Neurosci Res       Date:  2015-01-12       Impact factor: 4.164

2.  Critical Role of Endoplasmic Reticulum Stress in Chronic Intermittent Hypoxia-Induced Deficits in Synaptic Plasticity and Long-Term Memory.

Authors:  Lin-Hao Xu; Hui Xie; Zhi-Hui Shi; Li-Da Du; Yun-Kwok Wing; Albert M Li; Ya Ke; Wing-Ho Yung
Journal:  Antioxid Redox Signal       Date:  2015-05-08       Impact factor: 8.401

3.  Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein.

Authors:  Agata Gabryelska; Bartosz Szmyd; Janusz Szemraj; Robert Stawski; Marcin Sochal; Piotr Białasiewicz
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

4.  Intermittent Hypoxia Disrupts Adult Neurogenesis and Synaptic Plasticity in the Dentate Gyrus.

Authors:  Maggie A Khuu; Chelsea M Pagan; Thara Nallamothu; Robert F Hevner; Rebecca D Hodge; Jan-Marino Ramirez; Alfredo J Garcia
Journal:  J Neurosci       Date:  2018-12-26       Impact factor: 6.167

Review 5.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  Chronic intermittent hypoxia increases encoding pigment epithelium-derived factor gene expression, although not that of the protein itself, in the temporal cortex of rats.

Authors:  Guilherme Silva Julian; Renato Watanabe de Oliveira; Vanessa Manchim Favaro; Maria Gabriela Menezes de Oliveira; Juliana Cini Perry; Sergio Tufik; Jair Ribeiro Chagas
Journal:  J Bras Pneumol       Date:  2015 Jan-Feb       Impact factor: 2.624

Review 7.  The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS.

Authors:  Gatambwa Mukandala; Ronan Tynan; Sinead Lanigan; John J O'Connor
Journal:  Brain Sci       Date:  2016-02-17

8.  Intermittent Hypoxia Training Prevents Deficient Learning-Memory Behavior in Mice Modeling Alzheimer's Disease: A Pilot Study.

Authors:  Myoung-Gwi Ryou; Xiaoan Chen; Ming Cai; Hong Wang; Marianna E Jung; Daniel B Metzger; Robert T Mallet; Xiangrong Shi
Journal:  Front Aging Neurosci       Date:  2021-07-01       Impact factor: 5.750

9.  Intermittent Hypoxia causes targeted disruption to NMDA receptor dependent synaptic plasticity in area CA1 of the hippocampus.

Authors:  Alejandra Arias-Cavieres; Ateh Fonteh; Carolina I Castro-Rivera; Alfredo J Garcia
Journal:  Exp Neurol       Date:  2021-07-10       Impact factor: 5.620

10.  P2X7 Receptor Antagonism Attenuates the Intermittent Hypoxia-induced Spatial Deficits in a Murine Model of Sleep Apnea Via Inhibiting Neuroinflammation and Oxidative Stress.

Authors:  Yan Deng; Xue-Ling Guo; Xiao Yuan; Jin Shang; Die Zhu; Hui-Guo Liu
Journal:  Chin Med J (Engl)       Date:  2015-08-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.